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ABSTRACT 
Medicinal plants play an important role in the development of potent therapeutic agents. Plant based drugs provide outstanding contribution to 
modern therapeutics as a source of many valuable secondary metabolites which serves as plant defense mechanisms against predator such as 
microorganism, insects and herbivores which have been proved to be potentially active compounds. Euphorbia Thymifolia Linn (E. Thymifolia) 
is commonly known as ‘duddi’ or in Sanskrit means Laghu didhika or Raktavindaka. It belongs to the family Euphorbiceae. This plant is bitter, 
acrid, sweet and used as thermogenic, laxative and diuretic. This plant is widely used in the ayurveda to cure many diseases like vitiated 
condition of constipation, helminthiasis and ringworm skin diseases and leprosy. The aim of the present study is to examine E.Thymifolia Linn 
whole plant for phytochemical profile, Isolation and Identification of bioactive compounds. Qualitative analysis of various phytochemical 
constituents was determined by the well-known test protocol available in the literature. Isolation and characterization of bioactive compound 
from methanolic extract of E. Thymifolia has been conducted. The bioactive compound from methanolic extracts was isolated by several 
processes, such as TLC, column chromatography and preparative TLC. The isolated bioactive compound is identified by UV-Vis 
spectrophotometer, FT-IR, 1H, 13C-NMR and Mass. The obtained compound is continued to the preparative TLC using chloroform: methanol 
(50:50, v/v) as eluent. The UV-Vis spectrum showed one peaks of maximum absorbance at 312.8nm. Then, the FT-IR spectrum showed several 
peaks that confirmed the presence of functional group of derivative of compound, i.e. 669.05, 928.58, 1070.85, 1215.51 and 1710.07cm-1. 1H 
and 13C-NMR spectrum confirmed the bioactive compound present in plant. Phytochemical analysis revealed the presence of alkaloids, 
glycosides, phenols, flavonoids, tannins. The findings of the present study will be helpful to phytochemists, pharmacologists and pharmaceutical 
industries. 
Keywords: Euphorbia Thymifolia, Qualitative phytochemical, Isolation, Bioactive compounds 
 
Article Info: Received 18 March 2019;     Review Completed 2April 2019;     Accepted 24 April 2019;     Available online 15 May 2019 
Cite this article as: 
Shrivastava R, Mishra J, Extraction, Phytochemical Screening, Isolation and Identification of Bioactive Compounds from 
Extract of the plant Euphorbia Thymifolia Linn, Journal of Drug Delivery and Therapeutics. 2019; 9(3):107-113    
http://dx.doi.org/10.22270/jddt.v9i3.2608            
*Address for Correspondence:  
Rashmi Shrivastava, Department of Chemistry, Rabindranath Tagore University, Chiklod Rd, Mendua, Bhopal, Madhya Pradesh 464551 
 
INTRODUCTION 
Ayurveda stresses on the use of vegetable drugs. Plants are 
being used as medicine since ancient Times1,2. A numbers of 
bioactive compounds in medicinal plants, such as alkaloids, 
tannins, flavonoids, sterols, triterpenes, etc., are noted to 
play major role in physiology and management of diseases3. 
Flavonoids constitute one of the most exclusive classes of 
compounds in medicinal plants4. The foremost important 
task in this paradigm is the screening of flavonoids in plants. 
Phenolic compound are the most widely distributed 
secondary metabolites, ubiquitously present in the plant 
kingdom, even if the type of compound present varies 
according to the phylum under consideration. Phenolic are 
uncommon in varies bacteris, fungi and algae. Bryophytes 
are regular producers of polyphenols including flavonoids, 
but it is in the vascular plants that the full range of 
polyphenol is found5. Phenolic substances or polyphenols 
contain numerous varieties of compounds: simple 
flavonoids, phenolic acids, complex flavonoid and colored 
anthocyanins. These phenolic compounds are usually related 
to defense responses in the plant. However, phenolic 
metabolites play an important part in other processes, for 
instance incorporating attractive substance to accelerate 
pollination, coloring for camouflage and defense against 
herbivores, as well as antibacterial and atifungal activities6. 
Chromatographic studies of these compounds serves to be a 
very useful and reliable source in the process of bioactive 
compounds screening in plants7. According to the 
ethnobotanical information, it has been reported that the 
plant E. Thymifolia (family- Euphorbiaceae) is a medicinal 
herb used traditionally in dysentery, bleeding piles, 
gonorrhoea, dysmenorrhoea, amenorrhoea, helminthiasis, 
ringworm, chronic cough, asthma, bronchitis, cardiac 
debility, greying of hairs, skin diseases etc8, 9. E. Thymifolia 
have numerous pharmacological activities including 
antibacterial10, 11, antifungal12, antimicrobial13, anti-
inflammatory14,15, antiviral16, antispasmodic, bronchodilator, 
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antibronchial, asthmatic17-19, hypoglycaemic20-22, 
anticancer23,24 and antioxidant25. A number of chemical 
constituents are present in E. Thymifolia whole herb and its 
different parts. According to the literature, the whole plant 
contains epitaraxerol, n-hexacosanol, euphorbol, 24-
methylene cycloartenol, 12-deoxy-4P-hydroxyphorbol-13-
dodecanoate-20-acetate, 12-deoxy-4P-hydroxyphorbol-13-
phenylacetate-20-acetate, 12-deoxyphorbol-13,2O-diacetate, 
quercetin-3P-galactoside, 12-deoxyphorbol-l3,20-diacetate, 
12-deoxy-4Phydroxyphorbol-13-dodecanoate-20-acetate, n-
hexacosanol, esters, n-alkanes and sterols26,27. Roots contain 
taraxerol and triucallol. Leaves and stems consist of 4-
trihydroxy flavone-7- glycoside26. Leaves contain 
ellagitannin dimers, euphorbins G and H with 12 known 
polyphenols27-32. Therefore, the aim of this research is 
extraction, isolation, phytochemical screening and 
identification of bioactive compounds from methanolic 
extract of E. Thymifolia whole herb through several 
processes, such as thin layer chromatography, column 
chromatography and preparative TLC. To identify the 
structure of bioactive compound, several analyses has been 
conducted such as UV-Vis, FT-IR, 1H, 13C-NMR and mass. 
MATERIAL AND METHOD 
Plant material 
The whole plant material of E. Thymifolia was collected from 
the Betwa riverine zone of Vidisha during rainy seasons of 
the year 2014 and washed thoroughly with distilled water. It 
was identified and authenticated by Taxonomist Dr. Sunil 
Dubey, Department of Botany, St. Mary P. G. College, Vidisha 
(M.P.). A voucher specimen was procured which was 
deposited in Department of Botany and Microbiology, St. 
Mary’s P. G. College, Vidisha (M. P.) for future reference and 
the specimen voucher no. of E. Thymifolia is 104105. 
Chemical reagents 
All the chemicals used in this study were obtained from 
HiMedia Laboratories Pvt. Ltd. (Mumbai, India), Sigma 
Aldrich Chemical Co. (Milwaukee, WI, USA), SD Fine-Chem 
Chem. Ltd. (Mumbai, India) and SRL Pvt. Ltd. (Mumbai, 
India).All the chemicals used in this study were of analytical 
grade.  
Extraction Procedure 
Defatting of plant material 
Plant material of E. Thymifolia was shade dried at room 
temperature. The shade dried plant material was coarsely 
powdered and subjected to extraction with n-Hexane using 
soxhlation method. The extraction was continued till the 
defatting of the material had taken place. 
Extraction  
100gm of dried plant material were exhaustively extracted 
with different solvent in increasing order of polarity i.e. n-
Hexane, petroleum ether, benzene, acetone, methanol and 
distilled water using Soxhlet apparatus for 4 days. The 
extract was evaporated above their boiling points. Finally 
the percentage yields were calculated of the dried extracts. 
Dried extract was collected in an air tight container and 
stored at 4°C for further analysis33-36. 
Qualitative analysis of phytochemicals 
The methanolic extracts prepared for the study were 
subjected to preliminary phytochemical screening by using 
different reagents for identifying the presence or absence of 
various phytoconstituents viz., carbohydrates, proteins, 
alkaloids, tannins, steroid, flavonoids and terpenoids in 
methanolic extracts of E. Thymifolia. The above 
phytoconstituents were tested as per the standard method37. 
Fractionation of the extract by thin layer and column 
chromatography 
Thin layer chromatography 
The presence of different phytoconstituents in the 
methanolic extract of plant E. Thymifolia was established by 
TLC on silica coated alumina plates G’ 60 F254 plate of 0.2 
mm thickness by using different solvent systems as mobile 
phase. The selective solvent system used for the 
phytoconstituents detection was Chloroform (50): Methanol 
(50). A spotting capillary was used to add the extract to the 
plate. To spot the plate, simply touched the end of the 
capillary tube to the coated side of the plate and placed the 
TLC plate in the development chamber. The bottle was filled 
with a small amount of the mobile phase of solvent system 
and capped with a cork till complete development. After the 
complete development of spots on TLC plates, UV Chamber 
under the wavelength 254 nm of UV light was used to 
visualize the spots and the spots color were noticed. Besides 
this, Iodine chamber and visible light was also used to 
visualize the spots. RF (retention factor) values of the 
fractions were measured by applying formula of Brimley and 
Barrett38as: 
Distance travelled by the solvent 
     Rf  = ------------------------------------------------- 
Distance travelled by the solute 
Column chromatography 
In the present study, silica gel was used as a stationary phase 
which was poured in to the column then filled chloroform 
solvent as mobile phase and was run two three times for 
maintaining its flow by removing air bubbles entered during 
packaging of silica. Then loaded sample on the top of the 
column and filled the column with appropriate solvent 
systems. The selective solvent system used for phyto-
constituents detection was Chloroform: Methanol (50:50). 
Then, obtained purified fractions were separated on basis of 
their color characterization and were kept in separate vials 
for further analysis. 
Isolation and structural elucidation of the compound  
The biologically active purified fractions of the extract were 
sent to PBRL (Pinnacle Biomedical Research Laboratory), 
Bhopal for spectral analysis (UV) and to the SAIF CDRI, 
Lucknow for spectral analysis (IR, HNMR, CNMR and Mass) 
and spectral graphs were obtained. Which were interpreted 
with the literature available in books of spectroscopic 
analysis39,40. 
RESULTS AND DISCUSSION 
The crude extracts so obtained after the maceration process, 
extracts was further concentrated on water bath for 
evaporate the solvents completely to obtain the actual yield 
of extraction.  
Table 1: % Yield of plant material 
S. No. Solvents Euphorbia Thymifolia 
1 N- hexane 3.65% 
2. Pet. Ether 1.56% 
3. Benzene 2.96% 
4. Methanol 7.34% 
5. Aqueous 4.38% 
6. Acetone 3.83% 
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To obtain the percentage yield of extraction is very 
important phenomenon in phytochemical extraction to 
evaluate the standard extraction efficiency for a particular 
plant, different parts of same plant or different solvents 
used. The yield of extracts obtained from sample using 
chloroform, ethyl acetate, methanol and water as solvents 
are depicted in the Table 1. 
A small portion of the dried extracts were subjected to the 
phytochemical test using standard methods to test for 
alkaloids, glycosides, tannins, saponins, flavonoids and  
steroids separately for extracts of all samples. The outcomes 
of the results are discussed separately in the table 2.
 
Table 2: Preliminary phytochemical screening of Euphorbia Thymifolia (Linn.) extracts. 
S.  No. Tests  Phytochemicals Results 
1 • Mayer’s test 
• Wagner’s test 
• Dragendorff’s test 
• Hager’s test 
Alkaloids + 
2 • Molisch’s test 
• Benedict’s test 
• Fehling’s test 
Carbohydrates + 
3 • Modified Borntrager’s test 
• Legal’s test 
Glycosides + 
4 • Froth/Foam test Saponins _ 
5 • Salkowski’s test 
• Libermann-Burchard test 
Steroids + 
6 Gelatin test Tannins + 
7 Alkaline Reagent test 
• Lead acetate test 
Flavonoids + 
8 • Xanthoproteic test 
• Ninhydrin test 
Proteins 
and amino acids 
_ 
9 Test for Triterpenes Triterpenes + 
+ (present), - (Absent) 
In the present study, thin layer chromatography of E. 
Thymifolia whole plant crude methanolic extract was done 
and three spots of solutes were seen on the plate between 
the distance travelled by the solvent system (7.3 cm). These 
fractions of solutes were observed at 2.5cm, 5cm and 6.3cm 
distances, respectively Finally, RF (retention factor) values 
of the fractions were measured and given in table 3. 
 
Table 3 Thin layer chromatography of Euphorbia Thymifolia plant extract 
 
Plant Extract 
Of Euphorbia 
thymifolia 
 
Solvent System 
Used 
 
No. of 
spots 
 
RF Value 
 
Color characterization 
 
Visual light 
 
UV-light 
 
Iodine chamber 
Methanol 
 
Chloroform  (50) : 
Methanol (50) 
ET-1 
ET-2 
ET-3 
0.34  
0.68  
0.86 
Light yellow 
Yellow 
Brownish green 
Bluish yellow 
Dark yellow 
Bluish green 
Dark Yellow 
Dark brown 
Brownish green 
 
After the confirmation of solvent system applied in thin layer 
chromatography and obtained fractions of the extracts, the 
huge amount of extract was uploaded in column with the 
same solvent system after running column of silica gel with 
chloroform: methanol (50:50) solvent to separate the huge 
amount of the fractions of the extracts to use it for 
experimental bioassay. Four fractions of dark green, light 
green, pale yellow and red were obtained which were 
further used for experimental bio-assay and spectral 
analysis was given in table 4. 
 
Table 4 Column chromatography of Euphorbia Thymifolia plant extract 
Whole plant extract Solvent system used Fractions obtained Color characterization 
Euphorbia 
thymifolia 
 
Chloroform:Methanol 
(50:50) 
ET-1 
ET-2 
ET-3 
ET-4 
Dark green 
Light green 
Pale Yellow 
Red 
 
In the present study, biologically active purified fraction (ET-
2) of the E. Thymifolia whole plants methanolic extracts was 
analysed for the detection and confirmation of the bioactive 
compound present in the fraction. Sample of the purified 
fraction (ET-2) of E. Thymifolia was measured by using 
systronics double beam UV–VISIBLE Spectrophotometer 
Model 2202. Peaks as shown in fig. 1. Maximum absorbance 
of the extract 1.71 was reported at λmax312.8nm and 
minimum absorbance 0.511 was reported at λmax274.4nm 
wavelength (in 95% ETOH). The structured secondary band 
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which appeared as broad band at 312.8nm along with 
1.71absorbance confirms the presence of cyclohexane like 
compound. Another broad band appeared at λmax274.4nm 
along with 0.511 absorbance confirms the presence of cyclo-
pentane like compound in the purified fractions. 
 
 
Figure 1: UV spectra of purified fraction (ET-2). 
Sample ET-2 of E. Thymifolia was uploaded in Perkin Elmer 
Spectrum (Version 10.03.06) at SAIF, CDRI, Lucknow, (UP) 
by administrator to get IR spectra of the compound. Total 13 
peaks were reported in the sample (ET-2) of E. Thymifolia 
MEOH fraction as shown in fig 2 which described that in 
finger print region (<1500cm-1) 7 peaks were observed. The 
smallest peak at 669.05cm-1 belongs to the stretching 
vibration due to the presence of O-H group. Another peak at 
757.75cm-1 confirmed the presence of aromatic ring 
compound isomer especially on its ortho position in 
aromatic ring (770-735cm-1). The peak at 928.58cm-1 
showed Carbon Hydrogen banding vibration.  The peak at 
1070.85cm-1 explains the strong intensity of C-O stretching. 
The peak at 1215.51 cm-1 reports medium intensity of –C-N. 
A peak at 1384.12cm-1 explains carbon hydrogen banding 
vibration CH3. One more peak at 1640.96 cm-1 indicates for 
Aromatic ring compound. Besides this, a peak at 1710.07cm-1 
explains strong intensity of double bond between Carbon 
and Oxygen (C=O). Moreover, a peak at 2399.74cm-1 
describes strong and very broad intensity of carboxylic acid. 
A peak at 2855.13cm-1 also confirms the presence of cyclo-
pentane and hexane like compound that is probably λ-
Lactone. A small blunt peak at 2927.9cm-1 shows strong 
Carbon-Hydrogen stretching vibration (C-C-H), a peak at 
3019.12cm -1 depicts O-H group stretching and finally a last 
peak at 3408.99cm-1 describes strong and broad intensity of 
OH-group.
 
 
Figure 2: FT-IR Sspectra of purified fraction (ET-2) 
The 1HNMR (Agilent, CDCL3, 300MHz) peaks observed at 
different concentration (ppm) describes the position of 
hydrogen in the compounds. Three small peaks were 
reported between δ0.754 to 0.787 ranges signify for 3H (s) 
and eight medium peaks were reported between δ0.803 to 
δ0.898 ranges signify for 3H (s). Besides this, five peaks of 
small size were seen between δ0.920 to δ0.976 (2H, m), and 
twenty seven peaks between δ1.001 to δ1.730 were 
reported out of these, δ1.29 (16H, m), δ1.30 (2H, s), δ1.50 
(3H, s), δ1.62 (2H, m). Moreover, eight peaks were reported 
between the ranges of δ2.020 to δ2.806. Out of these peaks, 
δ2.03 (2H, m), δ2.05 (2H, m), two peaks were seen of δ5.352 
(1H,m), δ5.362 (1H, m) and finally, one  peak of δ7.265 was 
seen indicates for (2H, d, J=0.75Hz) as shown in fig 3 which 
confirms the presence of sesquiterpene lactones in the 
purified fraction. The 13CNMR (Agilent, 300MHz) peaks 
observed in the fig 4 at various concentration depicted the 
position of carbon and hybridization in the compound. First 
peak was of  δ12.17(q, sp3,CO-CH3), two peaks of δ14.32 and 
δ14.47 (t, sp2-sp, O-CH3), two peaks of δ16.16 and δ16.30 (d, 
sp, O-CH3), two peaks of δ18.19 and δ18.50 (t, C-3, sp2,2H,-
CH2), three peaks of δ19.23, 19.51and 19.94 (t, sp2, C-3, 2H,-
CH2), two peaks of δ20.01 and δ20.74 (t, sp2, C-10, 2H,-CH2), 
one peak of δ21.27(t, sp2, C-3, C-5, 2H,-CH2), three peaks of 
δ22.18, δ22.28 and δ22.89 (t, sp2,C-1), two peaks of δ24.66 
and δ24.95 and five peaks of δ25.22, δ25.62, δ25.72, δ25.81 
and δ25.93 (d, sp,-CH-), one peak of δ26.25ppm, two peaks 
of δ27.39 and δ27.79(s,-C), two peaks of δ28.17(t) and 
δ28.44 (t), six peaks of δ29.30 (t), δ29.36 (t), δ29.47 (t), 
δ29.56(t), δ29.66(t) and δ29.90 (t), one peak of δ30.98(t), 
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one peak of δ31.72 (t), two peaks of δ32.12 (t) and δ32.93 
(t), one peak of δ34.15 (t), one peak of δ36.34(t), two peaks 
of δ37.48(t) and δ37.63 (t), one peak of δ39.56, one peak of 
δ43.01, one peak of δ62.30 (q), one peak of δ63.23 (q), one 
peak of δ76.81(s), three peaks of δ77.23 (s), δ77.43 (s) and 
δ77.65 (s), two peaks of δ127.30 (d) and δ 127.94 (d), one 
peak of δ128.48 (d), one peak of δ130.41 (d), one peak of 
δ132.14 (s) and last peak of δ 178.69 (s). 
 
 
Figure 3: 1HNMR spectra of purified fraction (ET-2) 
 
Figure 4: 13CNMR spectra of purified fraction (ET-2) 
Mass spectrum of purified fraction of E. Thymifolia (ET-2) 
was analyzed for detection of biologically active compound 
on mass spectrometer and peaks were observed in the fig 5. 
In ESIMS, first peak was reported at 118.0860 (m/z) that 
confirms the presence of Phenyl Propene or Allyl Benzene or 
Indane with molecular formula C9H10 (Fig. 6A). A prominent 
spectral peak at 149.0232m/z confirms the presence of 2-
hydroxy pentane-dioic acid with molecular formula C5H8O5 
(Fig.6B). A largest peak reported at 391.2853m/z depicts 
the presence of Di-N-Octyl phthalate with molecular formula 
C24H38O4, (Fig.6C). A large peak at 279.1578m/z confirms 
the presence of 2-methoxyisoxazolidine-3, 3, 5, 5-tetra 
carboxylic acid with molecular formula C8H9NO10, (Fig.6D).  
A large peak reported at 441.3737m/z confirms the 
presence of 4α-Carboxy -4β-Methyl-5α-Cholesta-8, 24-dien-
3β-ol with molecular formula C29H45O3. (Fig.6E).  One of the 
peak reported at 593.2726m/z confirms the presence of 2-
(5’-O-Methyl-3’- YL-)-N-[(S)-1-(2’-α-Methoxy-3’-α-Methyl-5’-
Deoxythymidine-5’-YL)Ethyl] Acetamide  with molecular 
formula C27H39N5O10. (Fig.6F). Rest of the peaks was also 
seen in the mass spectrum which was found due to 
fragmentation of terpenoidal compound present in the bio-
active compound. 
 
  
Figure 5: MASS Spectra of purified fraction (ET-2) 
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Figure 6: (A) Phenyl Propene (B) 2–Hydroxypentanedioic acid  (C) Di-N-Octylphthalat (D) 2-methoxyisoxazolidine-3, 3, 
5, 5-tetracarboxylic (E) 4alpha-Carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol  (F) 2-(5'- O-Methyl-3'-
Deoxythymidin-3'-Yl)-N-[(S)-1(2'Alpha-Methoxy-3'-O-Methyl-5'-Deoxythymidin-5'-Yl) Ethyl]Acetamide 
CONCLUSION 
From the result obtained it can be concluded that the whole 
plant of E. Thymifolia has medicinal values since it contains 
more secondary metabolites. Bioactive compound (Total 6) 
were isolated and identified by column, thin layer 
chromatography and which were subjected to spectral 
analysis i.e. IR, UV, 1D NMR (1H-NMR and 13C-NMR) and 
mass spectroscopy from methanol extract of E. Thymifolia 
(ET-2) whole herb. These compounds have been reported 
for the first time in this plant and can serve as a useful tool in 
its standardization. Methanolic extracts shows good results 
regarding presence of phytoconstituents hence these plants 
may directly use in medicine preparation or for the 
development of novel agents for various pathological 
disorders. Further research on the health benefits of 
phytochemicals in this plant may be warranted. 
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